Skip to site menu Skip to page content

Daily Newsletter

Daily Newsletter

Moonwalk banks $70m to progress siRNA therapy for obesity

The company says its siRNA-based approach could spare lean muscle at an infrequent dosing schedule as obesity outcomes are defined by more than just weight loss.

Annabel Kartal Allen September 09 2026

Moonwalk says its siRNA-based obesity therapy could preserve lean muscle mass while operating on an infrequent dosing schedule. Credit: Studio Romantic / Shutterstock.com.

Unlock FREE Access to Premium Content

​Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends.

With a free Pharmaceutical Technology profile, you can:

  • Access exclusive analyst commentary and expert insights
  • View premium forecasts and data-driven pharmaceutical industry insights
  • Stay up to date with pharma news, manufacturing innovation, and regulatory developments
  • Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here

Powered by

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Browse reports

Newsletters by sectors

Clinical Trials Arena open-new-tab

Medical Device Network open-new-tab

Hospital Management open-new-tab

View more newsletters

Sign up to the newsletter

 

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close